​​​​Early results from an ongoing clinical trial suggest that a new drug being explored for treating IgA nephropathy, called atacicept, is safe and very beneficial for patients. A recent study showed the novel treatment can reduce the amount of protein leaking from patients’ kidneys by nearly half after just 36 weeks of treatment.

During the COVID-19 pandemic, there was an increase in peritoneal dialysis infection rates among kidney patients living in rural and First Nations communities in Northern BC. A new study suggests that an abrupt, pandemic-forced shift from Northern BC’s long-standing hybrid care model to virtual-only care eroded the trust and relational continuity that are foundational to … Read more

A team with the Island Health renal program evaluated a novel clinical tool designed to help decrease the number of unnecessary medications taken by people on hemodialysis, who often have a very high pill burden. The results could support more patients in safely stopping or tapering off medications they no longer need, in turn leading … Read more

​A new study shows that children and adolescents with hypertension (high blood pressure) have a 4.5 times greater risk of developing kidney disease when they become young adults compared to their peers without hypertension. The results, published in the Lancet Child & Adolescent Health, also show those with hypertension have an elevated risk of kidney … Read more